Journal of hepatologyJClub
Artificial intelligence and personalised medicine in liver cancer.
Journal of hepatology · · Review · Open access
Matuschewski, Baker + more
Abstract ↗AI summary
The abstract is read at the publisher; the summary is JClub's.
AI-driven multimodal models outperform single-modality approaches in predicting recurrence and survival in liver cancer patients.
- Why it matters: Current clinical frameworks only partially capture the complexity of liver cancer, limiting personalized treatment decisions and prognostic accuracy.
- What they did: The study reviews the application of machine learning and deep learning to multimodal data—including imaging, pathology, and clinical records—highlighting their potential to improve outcomes.
- The result: AI-based systems could enhance diagnosis, prognosis, and treatment selection, but require further validation, interpretability improvements, and integration to enable widespread clinical use.
The findingWhy it mattersWhat they didThe result
- Open access